Our Partnership
Key Structures
Topics
Results & Data
Impact Stories
-
20 January 2023Tanzania’s First Line of Defense Against Pandemics: Neema Vulugu
-
19 December 2022A Year in Review: 2022
-
24 November 2022Emergency HIV Prevention for People Displaced in Ukraine
-
16 November 2022Krystal’s Fight: Surviving Malaria as a Child to Combat the Disease Every Day as a Scientist
News Releases
-
02 February 2023
Global Fund Praises Luxembourg’s Additional Pledge, Bringing Total Contribution …
-
01 February 2023
African Leaders Unite in Pledge to End AIDS in Children
-
15 December 2022
Global Fund Welcomes Singapore’s Return As a Donor
-
14 December 2022
Global Fund and Private Sector Partners Launch US$50 Million Catalytic Fund to A…
Opinion
-
16 December 2022
The Criminalization of Sex Work Not Only Violates Human Rights – It Adds to HIV …
-
09 December 2022
A Hotline Operator’s Tireless Efforts to Keep People on Drug Treatment Despite W…
-
01 December 2022
The Best Way to Prepare for the Next Pandemic Is Not What You Think
-
30 November 2022
World AIDS Day: How are we supposed to protect our babies?
Updates
Featured
The Global Fund’s quality assurance information notices provide guidance and advice on how to operationalize in practical terms the consequences of a quality or a safety issue related to a product that has been procured with Global Fund funds. The initial information, stated in the notice, comes from the manufacturer of health products in question and/or is confirmed by stringent regulatory mechanisms.
-
Information Notices
-
QA Information Notice 2023-01: Temporary Suspension of procurement and delisting of TLD 300/300/50mg and EFV 600mg from Strides and manufactured by Universal Kenya and 3TC/ZDV 150/300 mg from Universal and manufactured by Universal Kenya
download in EnglishQA Information Notice 2023-01: Temporary Suspension of procurement and delisting of TLD 300/300/50mg and EFV 600mg from Strides and manufactured by Universal Kenya and 3TC/ZDV 150/300 mg from Universal and manufactured by Universal Kenya -
QA Information Notice 2022-03: Temporary Suspension of procurement and delisting of pharmaceutical products which do not satisfy the criteria for authorization on Bioequivalence
download in EnglishQA Information Notice 2022-03: Temporary Suspension of procurement and delisting of pharmaceutical products which do not satisfy the criteria for authorization on Bioequivalence -
The QA information notice 2022-01 has been withdrawn. All additional QC testing results comply with standards and therefore the potential quality issue has not been confirmed for the Artesunate powder for injection 60mg manufactured and commercialized by IPCA
-
QA Information Notice 2021-06: Precautionary Measures for GenoType MTBDRplus Ver 2.0 and MTBDRsl Ver 2.0 Supplied by Hain Lifescience GmbH, Germany
download in EnglishQA Information Notice 2021-06: Precautionary Measures for GenoType MTBDRplus Ver 2.0 and MTBDRsl Ver 2.0 Supplied by Hain Lifescience GmbH, Germany -
QA Information Notice 2021-05: Precautionary measures for products supplied by Agio Pharmaceuticals Ltd., India.
download in EnglishQA Information Notice 2021-05: Precautionary measures for products supplied by Agio Pharmaceuticals Ltd., India. -
QA Information Notice 2021-03: Precautionary measures in procuring IRS supplied by Bayer in water soluble bags
download in EnglishQA Information Notice 2021-03: Precautionary measures in procuring IRS supplied by Bayer in water soluble bags -
QA Information Notice 2021-02: Suspension of procurement of Personal Protective Equipment supplied by Protectcare, Bangalore (India)
download in EnglishQA Information Notice 2021-02: Suspension of procurement of Personal Protective Equipment supplied by Protectcare, Bangalore (India) -
QA Information Notice 2021-01: Reinstatement of lubricating gel supplied by Karex Industries Sdn Bhd in the UNFPA catalogue for procurement
download in EnglishQA Information Notice 2021-01: Reinstatement of lubricating gel supplied by Karex Industries Sdn Bhd in the UNFPA catalogue for procurement -
QA Information Notice 2020-07: To remind of the importance of manufacturer’s environmental conditions during storage, transportation and distribution for Clofazimine 100mg soft capsules manufactured by Sandoz Private Limited, Kalwe MIDC, Plot No.8-A/2, 8-B T.T.C, IND. AREA Village Dighe,Navi Mumbai, 400, India
download in EnglishQA Information Notice 2020-07: To remind of the importance of manufacturer’s environmental conditions during storage, transportation and distribution for Clofazimine 100mg soft capsules manufactured by Sandoz Private Limited, Kalwe MIDC, Plot No.8-A/2, 8-B T.T.C, IND. AREA Village Dighe,Navi Mumbai, 400, India -
QA Information Notice 2020-04: Falsified rapid diagnostic tests to detect HIV-1/2 circulating in Guyana and Kenya
download in EnglishQA Information Notice 2020-04: Falsified rapid diagnostic tests to detect HIV-1/2 circulating in Guyana and Kenya -
QA Information Notice 2020-02: Recall of Batches of Sofosbuvir 400mg tablets and Temporary suspension of procurement Sofosbuvir 400mg tablets, manufactured by European Egyptian Pharmaceutical Industry, Egypt
download in EnglishQA Information Notice 2020-02: Recall of Batches of Sofosbuvir 400mg tablets and Temporary suspension of procurement Sofosbuvir 400mg tablets, manufactured by European Egyptian Pharmaceutical Industry, Egypt -
QA Information Notice 2020-01: Serious Quality Management System issues reported on the manufacturing site of Access Bio Inc located 65 Clyde Rd. Suite A, Somerset, NJ 08873 (USA)
download in EnglishQA Information Notice 2020-01: Serious Quality Management System issues reported on the manufacturing site of Access Bio Inc located 65 Clyde Rd. Suite A, Somerset, NJ 08873 (USA) -
QA Information Notice 2019-09: Urgent Field Safety Notice for products manufactured by QIAGEN, QIAsymphony SP/AS - Operating the QIAsymphony SP with software version 5.0.3
download in EnglishQA Information Notice 2019-09: Urgent Field Safety Notice for products manufactured by QIAGEN, QIAsymphony SP/AS - Operating the QIAsymphony SP with software version 5.0.3 -
QA Information Notice 2019-07: Recall of Batches of Co-Trimoxazole 120mg Dispersible tablets and Temporary suspension of procurement of Co-Trimoxazole 120mg Dispersible tablets, manufactured by Chi Pharmaceuticals Limited, Nigeria
download in EnglishQA Information Notice 2019-07: Recall of Batches of Co-Trimoxazole 120mg Dispersible tablets and Temporary suspension of procurement of Co-Trimoxazole 120mg Dispersible tablets, manufactured by Chi Pharmaceuticals Limited, Nigeria -
QA Information Notice 2019-04: Suspension of manufacturing activities at Micro Labs Limited, Kumbalgodu, ML08, Bangalore (India)
download in EnglishQA Information Notice 2019-04: Suspension of manufacturing activities at Micro Labs Limited, Kumbalgodu, ML08, Bangalore (India) -
QA Information Notice 2019-03: The Global Fund Position on the UK MHRA Statement of non-compliance with Good Manufacturing Practices (GMP) for Micro Labs Limited, Unit 3, Hosur (India)
download in EnglishQA Information Notice 2019-03: The Global Fund Position on the UK MHRA Statement of non-compliance with Good Manufacturing Practices (GMP) for Micro Labs Limited, Unit 3, Hosur (India) -
QA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer
download in EnglishQA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer -
QA Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
download in EnglishQA Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
-
QA Information Notice 2023-01: Temporary Suspension of procurement and delisting of TLD 300/300/50mg and EFV 600mg from Strides and manufactured by Universal Kenya and 3TC/ZDV 150/300 mg from Universal and manufactured by Universal Kenya
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.